Pathogenetic mechanisms of parkin in Parkinson's disease

Lancet

Volumn 364, Issue 9435, 2004, Pages 722-724

  Hattori, Nobutaka ^a   Mizuno, Prof Yoshikuni ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PARKIN; TAU PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ENVIRONMENTAL FACTOR; EUROPE; FAMILY HISTORY; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR GENETICS; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; ANIMAL; BRAIN; GENETICS; HETEROZYGOTE; METABOLISM; MISSENSE MUTATION; ONSET AGE; POINT MUTATION;

AGE OF ONSET; ANIMALS; BRAIN; HETEROZYGOTE; HUMANS; MUTATION, MISSENSE; PARKINSON DISEASE; POINT MUTATION; TAU PROTEINS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 4344681293     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16901-8     Document Type: Short Survey

References (33)

1. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608
2. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology. 51:1998;890-892
3. Shimura H, Hattori N, Kubo S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 25:2000;302-305
4. Hattori N, Matsumine H, Kitada T, et al. Molecular analysis of a novel ubiquitin-like protein (PARKIN) gene in Japanese families with AR-JP. Ann Neurol. 44:1998;935-941
5. Lücking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 342:2000;1560-1567
6. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain. 126:2003;1271-1278
7. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain. 126:2002;1279-1292
8. Hedrich K, Djarmati A, Schafer N, et al. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology. 62:2004;389-394
9. Hilker R, Klein C, Ghaemi M, et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol. 49:2001;367-376
10. Klein C, Pramstaller PP, Kis B, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol. 48:2000;65-71
11. Oliveira SA, Scott WK, Martin ER, et al. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol. 53:2003;624-629
12. West AD, Maraganore D, Crook J, et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet. 11:2002;2787-2792
13. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol. 54:2003;176-185
14. Zhang Y, Gao J, Chung KK, et al. Parkin functions as an E2 dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle associated protein, CDCrel-1. Proc Natl Acad Sci USA. 97:2000;13354-13359
15. Imai Y, Soda M, Inoue H, et al. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell. 105:2001;891-902
16. Chung KK, Zhnag Y, Lim KL, et al. Parkin ubiquitinates the α-synuclein-interacting protein synphilin-1. Nat Med. 7:2001;1144-1150
17. Shimura H, Schlossmacher MG, Hattori N, et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implication for Parkinson's disease. Science. 293:2001;263-269
18. Staropoli JF, McDermott C, Martinat C, et al. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons form kainite excitotoxicity. Neuron. 37:2003;735-749
19. Ren Y, Zhao J, Feng J. Parkin binds to α-tubulin and increases their ubiquitination and degradation. J Neurosci. 23:2003;3316-3324
20. Corti O, Hampe C, Koutnikova H, et al. The p38 subunit of the aminoacyl-tRNA synthase complex is a parkin substrate. Hum Mol Genet. 12:2003;1427-1437
21. Huynh DP, Scoles DR, Neuyen D, et al. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet. 12:2003;2587-2597
22. Choi P, Snyder H, Petrucelli L, et al. SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res. 117:2003;179-189
23. Fallon L, Moreau F, Croft BG, et al. Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J Biol Chem. 277:2002;486-491
24. Huynh DP, Scoles DR, Ho TH, et al. Parkin is associated with actin filaments in neuronal and nonneuronal cells. Ann Neurol 2000; 48: 737-44.
25. Zhao J, Ren Y, Jiang Q, Feng J. Parkin is recruited to the centrosome in response to inhibition of proteasomes. J Cell Sci. 116:2003;4011-4019
26. Sakata E, Yamaguchi Y, Kurimoto E, et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4:2003;301-306
27. Itier J-M, Ibanez P, Mena MA, et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet. 12:2003;2277-2291
28. Goldberg MS, Fleming SM, Palacino JJ, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 278:2003;43628-43635
29. Greene JC, Whitworth AJ, Kuo I, et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA. 100:2003;4078-4083
30. Darios F, Corti O, Lucking CB, et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet. 12:2003;517-526
31. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol. 50:2001;293-300
32. van de Warrenburg BP, Lammens M, Lucking CB, et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology. 56:2001;555-557
33. Yang T, Nishimura I, Imai Y, et al. parkin suppressed dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron. 37:2003;911-924